An inactivated enterovirus 71 vaccine is safe and immunogenic in healthy adults: A phase I, double blind, randomized, placebo-controlled, study of two dosages

• Main Authors: Tambyah, Paul A, Oon, Jolene, Asli, Rosmonaliza, Kristanto, William, Hwa, Shi-Hsia, Vang, Fue, Karvval, Lovkesh, Fuchs, Jeremy, Santangelo, Joseph D, Gordon, Gilad S, Thomson, Cynthia, Rao, Raman, Dean, Hansi, Das, Subash C, Stinchcomb, Dan T
• Other Authors: YONG LOO LIN SCHOOL OF MEDICINE
• Format: Article
• Language: English
• Published: ELSEVIER SCI LTD 2021
• Subjects: Science & Technology; Life Sciences & Biomedicine; Immunology; Medicine, Research & Experimental; Research & Experimental Medicine; Enterovirus 71 vaccine; B2 sub-genotype; Phase I clinical trial; Immunogenicity; Seroconversion; Cross-neutralization; BINARY ETHYLENIMINE; MOUTH-DISEASE; ANTIBODY-RESPONSES; VIRUS; FOOT; HAND; ANTIGENICITY; INFECTION; MICE; IMMUNIZATION
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/206015
• Institution: National University of Singapore

10.1016/j.vaccine.2019.06.023